Incorporation of ovalbumin into ISCOMs and related colloidal particles prepared by the lipid film hydration method

International Journal of Pharmaceutics

Volumn 278, Issue 2, 2004, Pages 263-274

  Demana, Patrick H ^a   Davies, Nigel M ^b   Berger, Bianca ^a   Rades, Thomas ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

ISCOMs; Liposomes; Micelles; Ovalbumin; Quil A; Vaccine delivery

Indexed keywords

CHOLESTEROL; FLUORESCENT DYE; ISCOM; LIPOSOME; OVALBUMIN; PALMITIC ACID; PHOSPHATIDYLETHANOLAMINE; QUIL A; SAPONIN DERIVATIVE; TRITERPENE DERIVATIVE; VACCINE;

AQUEOUS SOLUTION; ARTICLE; COLLOID; DIALYSIS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SYNTHESIS; HYDRATION; LIPID COMPOSITION; LIPID MEMBRANE; MICELLE; PRIORITY JOURNAL;

CHOLESTEROL; COLLOIDS; DRUG DELIVERY SYSTEMS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; ISCOMS; OVALBUMIN; PHOSPHATIDYLETHANOLAMINES; SAPONINS; TECHNOLOGY, PHARMACEUTICAL;

EID: 2942573611     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.03.021     Document Type: Article

References (43)

1. Akerblom L., Nara P.N.D., Putney S., Morein B. HIV experimental vaccines based on the ISCOM technology using envelope and gag gene products. Biotechnol. Ther. 4:1993;145-161
2. Allen, T.M., 1983. Removal of detergent and solvent traces from liposomes. In: Gregoriadis, G. (Ed.), Liposome Technology. CRC Press, Inc., Florida, pp. 109-122.
3. Bangham A.D., Standish M.M., Watkins J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13:1965;238-262
4. Barr I.G., Mitchell G.F. ISCOMs (immunostimulating complexes): the first decade. Immunol. Cell Biol. 74:1996;8-25
5. Barr I.G., Sjölander A., Cox J.C. ISCOMs and other saponin based adjuvants. Adv. Drug Deliv. Rev. 32:1998;247-271
6. Bungener L., Huckriede A., Wilschut J., Daemen T. Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs. Biosci. Rep. 22:2002;323-338
7. Copland M.J., Rades T., Davies N.M. Hydration of lipid films with an aqueous solution of Quil A: a simple method for the preparation of immune-stimulating complexes. Int. J. Pharm. 196:2000;135-139
8. Demana P.H., Davies N.M., Vosgerau U., Rades T. Pseudo-ternary phase diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by the lipid-film hydration method. Int. J. Pharm. 270:2004;229-239
9. Devries, P., van Wezel, A.L., Beuvery, E.C. 1990. Process for preparing immunogenic complexes and pharmaceutical composition containing these complexes. USA Patent 4900549.
10. Ekström J., Hu K.F., Bengtsson K.L., Morein B. Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions. Vaccine. 17:1999;2690-2701
11. Höglund, S., Dalsgaard, K., Lövgren, K., Sundquist, B., Osterhaus, A., Morein, B., 1989. ISCOMs and immunostimulation with viral antigens. In: Harris, J.R. (Ed.), Subcellular Biochemistry. Plenum, New York, pp. 39-68.
12. Huang A., Tsao Y.S., Kennel S.J., Huang L. Characterization of antibody covalently coupled to liposomes. Biochim. Biophys. Acta. 1982:1982;140-150
13. Huang, L., Huang, A., Kennel, S.J., 1983. Coupling of antibodies with liposomes. In: Gregoriadis, G. (Ed.), Liposome Technology. CRC Press, Inc., Florida, pp. 51-73.
14. Hubbard M.J., McHugh N.J. Mitochondrial ATP synthase F-1-beta-subunit is a calcium-binding protein. FEBS Lett. 391:1996;323-329
15. Johansson M., Lövgren-Bengtsson K. ISCOMs with different quillaja saponin components differ in their immunomodulating activities. Vaccine. 17:1999;2894-2900
16. Kensil C.R. Saponins as vaccine adjuvants. Crit. Rev. Ther. Drug Carr. Syst. 13:1996;1-55
17. Kersten G.F.A., Crommelin D.J.A. Liposomes and ISCOMs as vaccine formulations. Biochim. Biophys. Acta-Rev. Biomembr. 1241:1995;117-138
18. Kersten G.F.A., Crommelin D.J.A. Liposomes and ISCOMs. Vaccine. 21:2003;915-920
19. Kersten G.F.A., Spiekstra A., Beuvery E.C., Crommelin D.J.A. On the structure of immune-stimulating saponin-lipid complexes (ISCOMs). Biochim. Biophys. Acta. 1062:1991;165-171
20. Kersten G.F.A., Vandeput A.M., Teerlink T., Beuvery E.C., Crommelin D.J.A. Immunogenicity of liposomes and ISCOMs containing the major outer-membrane protein of Neisseri-Gonorrhoeae - influence of protein-content and liposomal bilayer composition. Infect. Immun. 56:1988;1661-1664
21. Kirby C., Gregoriadis G. Dehydration-rehydration vesicles (DRV): a simple method for high yield drug entrapment in liposomes. Biotechnology. 2:1984;979-984
22. Kirby, C.J., Gregoriadis, G., 1983. Incorporation of factor VIII into liposomes. In: Gregoriadis, G. (Ed.), Liposome Technology. CRC Press, Florida.
23. Knight, C.G., 1981. Liposomes: From Physical Structure to Therapeutic Applications. Elsevier/North-Holland Biomedical Press, Amsterdam.
24. Könnings S., Copland M.J., Davies N.M., Rades T. A method for the incorporation of ovalbumin into immune stimulating complexes prepared by the hydration method. Int. J. Pharm. 241:2002;385-389
25. Morein B., Bengtsson K.L. Functional aspects of ISCOMs. Immunol. Cell Biol. 76:1998;295-299
26. Morein B., Bengtsson K.L. Immunomodulation by ISCOMs, immune stimulating complexes. Methods. 19:1999;94-102
27. Morein B., Ekström J., Lövgren K. Increased immunogenicity of a nonamphipathic protein (Bsa) after inclusion into ISCOMs. J. Immunol. Meth. 128:1990;177-181
28. Morein B., Lövgren K., Ronnberg B., Sjölander A., Villacres-Eriksson M. Immunostimulating complexes - clinical potential in vaccine development. Clin. Immunother. 3:1995;461-475
29. Mowat A.M., Donachie A.M. ISCOMs - a novel strategy for mucosal immunization. Immunol. Today. 12:1991;383-385
30. Mowat A.M., Smith R.E., Donachie A.M., Furrie E., Grdic D., Lycke N. Oral vaccination with immune stimulating complexes. Immunol. Lett. 65:1999;133-140
31. New, R.R.C., 1990. Liposomes: A Practical Approach. Oxford University Press, London.
32. Nisbet A.D., Saundry R.H., Moir J.G., Fothergill L.A., Fothergill J.E. The complete amino-acid sequence of hen ovalbumin. Eur. J. Biochem. 115:1981;335-345
33. Osterhaus, A., Rimmelzwaan, G.F., 1998. Induction of virus-specific immunity by ISCOMs. In: Brown, F., Haaheim, L. R. (Eds.), Modulation of the Immune Response to Vaccine Antigens. Karger, Basel, pp. 49-58.
34. Özel M., Höglund S., Gelderblom H.R., Morein B. Quaternary structure of the immunostimulating complex (ISCOM). 102:1989;240-248
35. Reid G. Soluble-proteins incorporate into ISCOMs after covalent attachment of fatty-acid. Vaccine. 10:1992;597-602
36. Rimmelzwaan, G., Osterhaus, A.D.M.E., 1997. ISCOMs: materials, preparation, antigen delivery and immune response. In: Gander, B., Merkle, H.P., Corradin, G. (Eds.), Antigen Delivery Systems: Immunological and Technological Issues. Harwood Academic Publishers, Amsterdam, pp. 123-138.
37. Sjölander A., Cox J.C., Barr I.G. ISCOMs: an adjuvant with multiple functions. J. Leukoc. Biol. 64:1998;713-723
38. Sjölander A., Drane D., Maraskovsky E., Scheerlinck J.P., Suhrbier A., Tennent J., Pearse M. Immune responses to ISCOM (R) formulations in animal and primate models. Vaccine. 19:2001;2661-2665
39. Sjölander A., VantLand B., Bengtsson K.L. ISCOMs containing purified Quillaja saponins upregulate both Th1-like and Th2-like immune responses. Cell. Immunol. 177:1997;69-76
40. Sjölander S., Drane D., Davis R., Beezum L., Pearse M., Cox J. Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses. Vaccine. 19:2001;4072-4080
41. Sundquist B., Lövgren K., Höglund S., Morein B. Influenza-virus ISCOMs - biochemical characterization. Vaccine. 6:1988;44-48
42. Weder, H.G., Zumbuehl, O., 1983. The preparation of variably sized homogeneous liposomes for laboratory, clinical, and industrial use by controlled detergent dialysis. In: Gregoriadis, G. (Ed.), Liposome Technology. CRC Press, Florida, pp. 79-107.
43. Windholz, M., Budavari, S., Blumetti, R.F., Otterbein, E.S., (Eds.), 1983. The Merck Index, 10th Edition, Rahway, New Jersey, USA.